Rekord LOINC: 94327-4
Tylko wersja angielska ACTIVE
Szczegóły rekordu LOINC
Informacje podstawowe
| Kod LOINC: |
94327-4
FHIR
|
| Long Common Name: | PhenX - human papillomavirus vaccine use protocol 100802 |
| Short Name: | PhenX - HPV vaccine use protocol |
| Status: | ACTIVE |
| Class Type: | 2 |
Fully Specified Name (FSN)
Klasyfikacja
| Class: |
ENPANEL.PHENX
|
| Consumer Name: | - |
| Order/Observation: | Order |
| Panel Type: | Panel |
Informacje dodatkowe
| Units Required: | - |
| Example Units: | - |
| UCUM Units: | - |
| Version Last Changed: | 2.68 |
Definicja i opis
The interviewer asks the individual whether s/he ever received a human papillomavirus (HPV) vaccination. If the response is yes, the interviewer asks about number of shots received. If the participant answers "yes" to question 1, the interviewer should complete the rest of the protocol. If the participant answers "no," then the protocol is deemed complete. The PhenX Working Group notes that GARDASIL® is also known internationally as Silgard. European Medicines Agency. (2009, September 25). Silgard European Public Assessment Report. Waknine, Y. (2006, October 2). International approvals: Singulair and Gardasil/Silgard. Medscape Today. Note: GARDASIL® by Merck & Co. is approved by the U.S. Food and Drug Administration (FDA) for use in females ages 9-26 and males ages 9-26. Note: CERVARIX® is manufactured by GlaxoSmithKline Biologicals and approved by the FDA for use in females ages 10-25.
Powiązane nazwy
Pan; Panel; PANEL.PHENX; Panl; PhenX - HPV vaccine use protocol; Pnl; Point in time; Random
Struktura panelu
Ładowanie struktury panelu...